DSDavid P. Speert

David P. Speert

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


David P. Speert has a total of 49 co-authors. Here are the top co-authors by number of shared publications:

  • Eshwar Mahenthiralingam

    Cardiff University

    4 shared publications
  • Deborah A. Henry

    Divisions of Infectious and Immunological Diseases and Biochemical Diseases, Department of Pediatrics, University of British Columbia; and British Columbia Institute for Children's and Women's Health and Cystic Fibrosis Clinic, Children's and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada

    3 shared publications
  • Peter Vandamme

    Laboratory of Microbiology, Faculty of Sciences, Ghent University, K. L. Ledeganckstraat 35, 9000 Ghent, Belgium

    3 shared publications
  • A. George F. Davidson

    Divisions of Infectious and Immunological Diseases and Biochemical Diseases, Department of Pediatrics, University of British Columbia; and British Columbia Institute for Children's and Women's Health and Cystic Fibrosis Clinic, Children's and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada

    2 shared publications
  • Lawrence T. K. Wong

    Divisions of Infectious and Immunological Diseases and Biochemical Diseases, Department of Pediatrics, University of British Columbia; and British Columbia Institute for Children's and Women's Health and Cystic Fibrosis Clinic, Children's and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada

    2 shared publications
  • Maureen E. Campbell

    Divisions of Infectious and Immunological Diseases and Biochemical Diseases, Department of Pediatrics, University of British Columbia; and British Columbia Institute for Children's and Women's Health and Cystic Fibrosis Clinic, Children's and Women's Hospital of British Columbia, Vancouver, British Columbia, Canada

    2 shared publications

Latest Publications

  • Biofilm Formation and Acyl Homoserine Lactone Production in the Burkholderia cepacia Complex

    by Barbara-Ann D. Conway, Vicnays Venu, David P. Speert

    Acyl homoserine lactone (acyl-HSL)-mediated gene regulation has been shown to influence biofilm formation in one Burkholderia cepacia cystic fibrosis isolate, but it is not known whether this relationship is a consistent feature of the several genomic species that make up the B. cepacia complex (BCC). We screened strains belonging to genomovars I to V of the BCC for biofilm formation on an abiotic surface and for acyl-HSL synthesis. We determined that organisms from each of these genomovars were capable of biofilm formation. Similarly, acyl-HSL was synthesized by organisms from each of genomovars I to V, with most isolates producing octanoyl-HSL in greatest abundance. When biofilms were grown in Luria broth, acyl-HSL synthesis and biofilm formation appeared to be associated, but these phenotypes were independent when the biofilms were grown in basal salts containing citrate. Genomovar V strains synthesized the greatest quantities of acyl-HSL, and genomovar II and III-A strains elaborated the most abundant biofilms. Quorum sensing may play a role in BCC pathogenesis, but it may not regulate biofilm formation under all growth conditions.


  • Evaluation of a diagnostic polymerase chain reaction assay for Neisseria meningitidis in North America and field experience during an outbreak.

    by Andrew J Pollard, Gary Probe, Colleen Trombley, Annette Castell, Sue Whitehead, J Mark Bigham, Sylvie Champagne, Judy Isaac-Renton, Rusung Tan, Malcolm Guiver, et al.

    Meningococcal infection has a high public profile because of its dramatic presentation, high fatality rate, and propensity to occur in outbreaks and clusters of cases. Use of a diagnostic polymerase chain reaction (PCR) assay could enhance laboratory confirmation of cases and guide the public health response in North America. To assess the performance of a PCR assay for the diagnosis of meningococcal disease after its implementation in a North American setting and to evaluate sensitivity and specificity of the assay for the detection of prevalent bacterial isolates. Laboratory evaluation of the sensitivity and specificity of a PCR assay for Neisseria meningitidis and observational study of a series of cases comparing molecular diagnosis against the criterion standard of conventional laboratory diagnostic tests. A Canadian province with a population of 4 million people. Children and adults presenting with suspected meningococcal disease in British Columbia. The sensitivity and specificity of the PCR assay when compared against standard laboratory methods. The PCR assay correctly identified all of 38 Canadian isolates of Neisseria meningitidis and correctly assigned the serogroup to each isolate. None of 57 other gram-positive or gram-negative bacteria or yeasts were detected by the PCR assay. In a clinical evaluation, for diagnosis of meningococcal disease, the PCR assay had a sensitivity and specificity of 91% and 76%, respectively, against conventional methods of diagnosis. Use of the PCR assay increased the laboratory confirmation of clinically suspected cases by 36%. During an outbreak, the PCR assay allowed serogroup determination in 3 of 7 cases, aiding in the public health decision to launch an immunization campaign. The PCR assay is more sensitive than conventional methods for the diagnosis of meningococcal disease, and enhanced surveillance may help direct the public health response to the changing epidemiology of disease in North America.


  • Epidemiology of Pseudomonas aeruginosa in Cystic Fibrosis in British Columbia, Canada

    by David P. Speert, Maureen E. Campbell, Deborah A. Henry, Ruth Milner, Fatma Taha, Anna Gravelle, A. George F. Davidson, Lawrence T. K. Wong, Eshwar Mahenthiralingam

    Pseudomonas aeruginosa is the most common respiratory pathogen in patients with cystic fibrosis (CF), but the predominant mechanism by which it is acquired is controversial. To determine the frequency of patient-to-patient spread, we evaluated P. aeruginosa isolates from 174 patients treated at the CF clinics in Vancouver, BC, Canada, since 1981. Multiple isolates were obtained from each patient and genetically typed by random amplified polymorphic DNA and pulsed field gel electrophoresis analyses. A total of 157 genetic types of P. aeruginosa was identified, 123 of which were unique to individual patients. A total of 34 types was shared by more than one patient; epidemiologic evidence linked these individuals only in the cases of 10 sibships and 1 pair of unrelated patients. We conclude that there is an extremely low risk in Vancouver for patients with CF to acquire P. aeruginosa from other patients. It appears that prolonged close contact, such as occurs between siblings, is necessary for patient-to-patient spread. The major source of acquisition of P. aeruginosa in CF appears to be from the environment. Considering these observations, we do not recommend segregation of patients with CF on the basis of their colonization status with P. aeruginosa.


  • Open Access

    Differential Persistence among Genomovars of theBurkholderia cepaciaComplex in a Murine Model of Pulmonary Infection

    by Karen K. Chu, Donald J. Davidson, T. Keith Halsey, Jacqueline W. Chung, David P. Speert

    Cystic fibrosis patients infected with strains from different genomovars of theBurkholderia cepaciacomplex can experience diverse clinical outcomes. To identify genomovar-specific determinants that might be responsible for these differences, we developed a pulmonary model of infection in BALB/c mice. Mice were rendered leukopenic by administration of cyclophosphamide prior to intranasal challenge with 1.6 × 104bacteria. Five of six genomovar II strains persisted at stable numbers in the lungs until day 16 with minimal toxicity, whereas zero of seven genomovar III strains persisted but resulted in variable toxicity. We have developed a chronic pulmonary model ofB. cepaciainfection which reveals differences among genomovars in terms of clinical infection outcome.


  • Open Access

    Epidemiology of Burkholderia cepacia Complex in Patients with Cystic Fibrosis, Canada

    by David P. Speert, Deborah Henry, Peter Vandamme, Mary Corey, Eshwar Mahenthiralingam

    The Burkholderia cepacia complex is an important group of pathogens in patients with cystic fibrosis (CF). Although evidence for patient-to-patient spread is clear, microbial factors facilitating transmission are poorly understood. To identify microbial clones with enhanced transmissibility, we evaluated B. cepacia complex isolates from patients with CF from throughout Canada. A total of 905 isolates from the B. cepacia complex were recovered from 447 patients in 8 of the 10 provinces; 369 (83%) of these patients had genomovar III and 43 (9.6%) had B. multivorans (genomovar II). Infection prevalence differed substantially by region (22% of patients in Ontario vs. 5% in Quebec). Results of typing by random amplified polymorphic DNA analysis or pulsed-field gel electrophoresis indicated that strains of B. cepacia complex from genomovar III are the most potentially transmissible and that the B. cepacia epidemic strain marker is a robust marker for transmissibility.


  • Open Access

    Infection withBurkholderia cepaciaComplex Genomovars in Patients with Cystic Fibrosis: Virulent Transmissible Strains of Genomovar III Can ReplaceBurkholderia multivorans

    by Eshwar Mahenthiralingam, Peter Vandamme, Maureen E. Campbell, Deborah A. Henry, Anna M. Gravelle, Lawrence T. K. Wong, A. George F. Davidson, Pearce G. Wilcox, Barbara Nakielna, David P. Speert

    Infection with Burkholderia cepacia complex in patients with cystic fibrosis (CF) results in highly variable clinical outcomes. The purpose of this s


  • Adherence of Burkholderia cepacia to respiratory tract epithelial cells and inhibition with dextrans

    by Cheng-Hsun Chiu, Simon Wong, Robert E. W. Hancock, David P. Speert

    Adherence of Burkholderia cepacia to cells of the respiratory tract of patients with cystic fibrosis (CF) appears to be a necessary precondition for colonization and infection. To date, no effective anti-adhesive strategy has been devised for preventing B. cepacia infection in CF patients. It was found in this study that B. cepacia adhered to respiratory epithelial cells both in vitro and in vivo. However, strains with cable-like pili (Cbl) exhibited the typical clump formation on pneumocytes, whereas non-cable piliated strains predominantly showed single-cell adherence. Dextrans (nominally 4000–10000 Da) significantly inhibited adhesion of B. cepacia to A549 pneumocytes. When compared on an equal weight basis, the nominally 10000 Da dextran was most inhibitory. A dose-dependent inhibitory effect (up to 80 mg ml−1) was observed for most strains. Dextran exerted less of an anti-adhesive effect on the two Cbl+ strains than on the others which were Cbl−. Dextrans appeared to block the adherence in a non-specific fashion, as shown by the observations that the inhibitory effect was readily reversible and oligosaccharides composed of 2–4 glucose units with the same α-1,6 linkage were not inhibitory. The mean molecular masses of dextrans used in this study, as determined by gel filtration and MS, were approximately 10-fold lower than those indicated by the manufacturers. Our data suggest that dextran of nominal molecular mass 4000 Da at a concentration of 40 mg ml−1 (10 mM according to manufacturer’s quoted molecular mass) or more may be useful in patients with CF to prevent colonization and infection with B. cepacia.


  • Open Access

    Two Distinct Receptors Mediate Nonopsonic Phagocytosis of Different Strains ofPseudomonas aeruginosa

    by John‐Paul Heale, Andrew J. Pollard, Richard W. Stokes, David Simpson, Angela Tsang, Bonnie Massing, David P. Speert

    Complement receptor 3 (CR3) mediates both opsonic and nonopsonic phagocytosis of bacteria. Leukocyte adhesion deficiency (LAD) allows for the study o


  • Open Access

    Phenotypic Methods for Determining Genomovar Status of the Burkholderia cepacia Complex

    by Deborah A. Henry, Eshwar Mahenthiralingam, Peter Vandamme, Tom Coenye, David P. Speert

    Recent taxonomic advances have demonstrated that Burkholderia cepacia is a cluster of at least seven closely related genomic species (or genomovars) collectively referred to as the B. cepacia complex, all of which may cause infections among cystic fibrosis patients and other vulnerable individuals. Thus, it is important for clinical microbiologists to be able to differentiate genomovars. Prior to this study, 361 B. cepacia complex isolates and 51 isolates easily confused with B. cepacia complex previously had been identified using a polyphasic approach, and in this study, a comparison of phenotypic and biochemical tests was carried out. It was determined that Burkholderia multivorans and Burkholderia stabilis could reliably be separated from other members of the B. cepacia complex by phenotypic methods. A combination of phenotypic and molecular tests such as recA PCR and 16S rRNA RFLP are recommended for differentiation among the genomovars of the B. cepacia complex. A biochemical reaction scheme for the identification of B. gladioli , Pandoraea species, and Ralstonia pickettii and the differentiation of these species from the B. cepacia complex is also presented.


  • Evaluation of Random Amplified Polymorphic DNA Typing of Pseudomonas aeruginosa

    by Maureen Campbell, Eshwar Mahenthiralingam, David P. Speert

    A method for distinguishing among Pseudomonas aeruginosa strains using random amplified polymorphic DNA (RAPD) typing was evaluated for reproducibility and discriminatory power. A total of 200 isolates, blinded in triplicate, were evaluated by RAPD. All 600 samples were typeable; 197 of 200 isolates gave identical results on all three occasions, and 131 distinct RAPD types were identified.